Mark H. Tuszynski

33.2k total citations · 8 hit papers
232 papers, 23.4k citations indexed

About

Mark H. Tuszynski is a scholar working on Cellular and Molecular Neuroscience, Developmental Neuroscience and Pathology and Forensic Medicine. According to data from OpenAlex, Mark H. Tuszynski has authored 232 papers receiving a total of 23.4k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Cellular and Molecular Neuroscience, 101 papers in Developmental Neuroscience and 70 papers in Pathology and Forensic Medicine. Recurrent topics in Mark H. Tuszynski's work include Nerve injury and regeneration (150 papers), Neurogenesis and neuroplasticity mechanisms (100 papers) and Spinal Cord Injury Research (69 papers). Mark H. Tuszynski is often cited by papers focused on Nerve injury and regeneration (150 papers), Neurogenesis and neuroplasticity mechanisms (100 papers) and Spinal Cord Injury Research (69 papers). Mark H. Tuszynski collaborates with scholars based in United States, Germany and Canada. Mark H. Tuszynski's co-authors include Armin Blesch, Paul Lu, Leonard L. Jones, J. M. Conner, Alan H. Nagahara, Fred H. Gage, Ray Grill, Andrea A. Chiba, Edmund Hollis and Lori Graham and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Mark H. Tuszynski

227 papers receiving 23.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

2009 837 citations Alan H. Nagahara, David A. Merrill et al. Nature Medicine profile →
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

2005 780 citations Mark H. Tuszynski, Hoi Sang U et al. Nature Medicine profile →
Potential therapeutic uses of BDNF in neurological and psychiatric disorders

2011 708 citations Alan H. Nagahara, Mark H. Tuszynski profile →
Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury

2003 690 citations Paul Lu, Mark H. Tuszynski et al. Experimental Neurology profile →
Long-Distance Growth and Connectivity of Neural Stem Cells after Severe Spinal Cord Injury

2012 679 citations Paul Lu, Yaozhi Wang et al. profile →
Biomimetic 3D-printed scaffolds for spinal cord injury repair

2019 545 citations Jacob Koffler, Wei Zhu et al. Nature Medicine profile →
Cellular Delivery of Neurotrophin-3 Promotes Corticospinal Axonal Growth and Partial Functional Recovery after Spinal Cord Injury

1997 512 citations Armin Blesch, Fred H. Gage et al. Journal of Neuroscience profile →
Regulation of axonal regeneration after mammalian spinal cord injury

2023 165 citations Binhai Zheng, Mark H. Tuszynski profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark H. Tuszynski United States	89	14.3k	7.6k	7.0k	5.7k	3.0k	232	23.4k
James W. Fawcett United Kingdom	93	18.7k 1.3×	8.5k 1.1×	5.5k 0.8×	10.2k 1.8×	2.4k 0.8×	325	31.2k
Martin E. Schwab Switzerland	101	21.8k 1.5×	13.0k 1.7×	9.7k 1.4×	8.7k 1.5×	3.2k 1.0×	397	35.2k
Jerry Silver United States	75	14.0k 1.0×	7.8k 1.0×	5.5k 0.8×	7.0k 1.2×	1.7k 0.6×	151	22.2k
Michael V. Sofroniew United States	90	14.0k 1.0×	9.0k 1.2×	4.9k 0.7×	11.8k 2.1×	1.9k 0.6×	191	37.4k
Wolfram Tetzlaff Canada	68	7.9k 0.6×	5.0k 0.7×	5.3k 0.8×	4.1k 0.7×	2.0k 0.6×	201	15.9k
Michael S. Beattie United States	50	6.1k 0.4×	2.7k 0.4×	9.4k 1.3×	2.5k 0.4×	3.2k 1.0×	145	15.6k
Mary Bartlett Bunge United States	71	10.9k 0.8×	6.0k 0.8×	5.6k 0.8×	3.5k 0.6×	2.5k 0.8×	158	15.5k
Xavier Navarro Spain	71	10.4k 0.7×	2.0k 0.3×	1.9k 0.3×	2.9k 0.5×	3.4k 1.1×	390	18.1k
Oswald Steward United States	84	15.8k 1.1×	5.2k 0.7×	2.8k 0.4×	9.6k 1.7×	1.2k 0.4×	292	24.9k
Stephen B. McMahon United Kingdom	98	17.0k 1.2×	3.8k 0.5×	3.5k 0.5×	7.9k 1.4×	2.5k 0.8×	340	33.9k

Countries citing papers authored by Mark H. Tuszynski

Since Specialization

Citations

This map shows the geographic impact of Mark H. Tuszynski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Tuszynski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Tuszynski more than expected).

Fields of papers citing papers by Mark H. Tuszynski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark H. Tuszynski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Tuszynski. The network helps show where Mark H. Tuszynski may publish in the future.

Co-authorship network of co-authors of Mark H. Tuszynski

This figure shows the co-authorship network connecting the top 25 collaborators of Mark H. Tuszynski. A scholar is included among the top collaborators of Mark H. Tuszynski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark H. Tuszynski. Mark H. Tuszynski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jakabek, David, Adrian M. Isaacs, Bart De Strooper, et al.. (2025). CTAD taskforce: genetic therapies in Alzheimer’s disease. The Journal of Prevention of Alzheimer s Disease. 12(8). 100269–100269. 1 indexed citations

Lu, Paul, et al.. (2024). A facilitatory role of astrocytes in axonal regeneration after acute and chronic spinal cord injury. Experimental Neurology. 379. 114889–114889. 6 indexed citations

Zdunowski, Sharon, Hui Zhong, Jessica L. Nielson, et al.. (2023). Emergence of functionally aberrant and subsequent reduction of neuromuscular connectivity and improved motor performance after cervical spinal cord injury in Rhesus. SHILAP Revista de lepidopterología. 4. 1205456–1205456. 1 indexed citations

Castle, Michael J., Fernando C. Baltanás, Imre Kovács, et al.. (2020). Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery. Human Gene Therapy. 31(7-8). 415–422. 81 indexed citations

Koffler, Jacob, Wei Zhu, Xin Qu, et al.. (2019). Biomimetic 3D-printed scaffolds for spinal cord injury repair. Nature Medicine. 25(2). 263–269. 545 indexed citations breakdown →

Nagahara, Alan H., Bayard Wilson, Iryna Ivasyk, et al.. (2018). MR-guided delivery of AAV2-BDNF into the entorhinal cortex of non-human primates. Gene Therapy. 25(2). 104–114. 43 indexed citations

Zuidema, Jonathan M., Tushar Kumeria, Dokyoung Kim, et al.. (2018). Oriented Nanofibrous Polymer Scaffolds Containing Protein‐Loaded Porous Silicon Generated by Spray Nebulization. Advanced Materials. 30(12). e1706785–e1706785. 40 indexed citations

Poplawski, Gunnar, Richard Lie, Matthew A. Hunt, et al.. (2018). Adult rat myelin enhances axonal outgrowth from neural stem cells. Science Translational Medicine. 10(442). 31 indexed citations

Shahriari, Dena, Jacob Koffler, Mark H. Tuszynski, W. Marie Campana, & Jeff Sakamoto. (2017). Hierarchically Ordered Porous and High-Volume Polycaprolactone Microchannel Scaffolds Enhanced Axon Growth in Transected Spinal Cords. Tissue Engineering Part A. 23(9-10). 415–425. 41 indexed citations

10.

Kadoya, Ken, Paul Lu, Kenny Nguyen, et al.. (2016). Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration. Nature Medicine. 22(5). 479–487. 285 indexed citations

11.

Lu, Paul, Lori Graham, Yaozhi Wang, Di Wu, & Mark H. Tuszynski. (2014). Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury. Journal of Visualized Experiments. e50641–e50641. 50 indexed citations

12.

Conner, J. M., Kevin M. Franks, Andrea K. Titterness, et al.. (2009). NGF Is Essential for Hippocampal Plasticity and Learning. Journal of Neuroscience. 29(35). 10883–10889. 163 indexed citations

13.

Alfa, Ronald W., Mark H. Tuszynski, & Armin Blesch. (2009). A novel inducible tyrosine kinase receptor to regulate signal transduction and neurite outgrowth. Journal of Neuroscience Research. 87(12). 2624–2631. 11 indexed citations

14.

Kordower, Jeffrey H. & Mark H. Tuszynski. (2008). CNS regeneration : basic science and clinical advances. Academic Press eBooks. 15 indexed citations

15.

Courtine, Grégoire, Roland R. Roy, John A. Hodgson, et al.. (2005). Kinematic and EMG Determinants in Quadrupedal Locomotion of a Non-Human Primate (Rhesus). Journal of Neurophysiology. 93(6). 3127–3145. 107 indexed citations

16.

Tuszynski, Mark H. & Armin Blesch. (2004). Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease. Progress in brain research. 146. 439–449. 93 indexed citations

17.

Merrill, David A., Jeffrey A. Roberts, & Mark H. Tuszynski. (2000). Conservation of neuron number and size in entorhinal cortex layers II, III, and V/VI of aged primates. The Journal of Comparative Neurology. 422(3). 396–401. 82 indexed citations

18.

Bowes, Mark P., et al.. (2000). Continuous intrathecal fluid infusions elevate nerve growth factor levels and prevent functional deficits after spinal cord ischemia. Brain Research. 883(2). 178–183. 13 indexed citations

19.

Tuszynski, Mark H., Hoi Sang U, Kazunari Yoshida, & Fred H. Gage. (1991). Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Annals of Neurology. 30(5). 625–636. 145 indexed citations

20.

Gage, Fred H., Lisa J. Fisher, Hyder A. Jinnah, et al.. (1990). Chapter 1 Grafting genetically modified cells to the brain: conceptual and technical issues. Progress in brain research. 82. 1–10. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact